Your Complete Guide to Starting Wegovy Safely and Successfully
When Do Wegovy Side Effects Start During Your First Week?
Most patients wonder when Wegovy side effects start, and the answer varies between individuals. Typically, side effects begin within 24-72 hours after your first 0.25mg injection, with the most common early symptoms being mild nausea, reduced appetite, and subtle digestive changes. The starter dose of 0.25mg is specifically designed to minimise these initial effects whilst allowing your body to adjust gradually to semaglutide. Understanding when Wegovy side effects start helps you prepare mentally and practically for your weight management journey.
During your first week, you might notice decreased hunger between meals, slight queasiness around mealtimes, or feeling satisfied with smaller portions than usual. These early signs actually indicate that Wegovy is beginning to work on your brain's appetite centres. The 0.25mg starter dose is intentionally low to reduce the intensity of initial side effects whilst establishing the medication's mechanism in your system. Most patients find these early symptoms manageable and often welcome the appetite reduction as a positive sign of progress.
Wegovy 0.25mg Starter Pricing and Bundle Options
Our Wegovy 0.25mg starter dose costs £79.99, designed specifically for weeks 1-4 of your treatment journey. New customers can apply code FIRST40 at checkout to reach this price, whilst returning customers use DOSE25. For comprehensive first-month support, consider our Intro Duo bundle (0.25mg plus 0.5mg) for £169.99, providing both your starter dose and next progression step. This bundle ensures seamless transition without reordering delays, maintaining treatment continuity during the crucial early weeks.
When planning your Wegovy journey, remember that dose escalation occurs every four weeks according to clinical protocols. Our Intro Trio bundle (0.25mg, 0.5mg, and 1mg) at £299.99 covers your first 12 weeks, eliminating multiple orders and ensuring Reliable Supply. All bundles include the same next-day cold-chain delivery and clinical support as individual pens. Payment is processed securely, and each pen arrives with comprehensive administration guidance and side effect management advice from our qualified clinical team.
Clinical Evidence: When Do Wegovy Side Effects Start in STEP Trials?
Clinical research from the landmark STEP trials provides valuable insight into when Wegovy side effects start and their typical progression. In STEP 1, involving 1,961 participants, gastrointestinal side effects were most commonly reported within the first two weeks of treatment initiation. The study showed that patients taking Wegovy alongside diet and exercise experienced manageable side effects that generally decreased in intensity over the first month of treatment.
According to Wilding et al., NEJM, 2021, the dose escalation protocol was specifically designed based on tolerability data from thousands of patients. Starting at 0.25mg allows gradual physiological adaptation, with most participants in the STEP trials successfully progressing through each dose level. The research demonstrates that understanding when Wegovy side effects start, combined with proper clinical support, leads to better treatment adherence and long-term success rates compared to rapid dose initiation.
How Wegovy Works: Understanding the Side Effect Timeline
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. When you inject your first 0.25mg dose, semaglutide begins binding to GLP-1 receptors in your brain's appetite centres and digestive system, which explains why side effects typically begin within 24-72 hours. The medication slows gastric emptying, meaning food stays in your stomach longer, creating sustained fullness but potentially causing initial nausea in some patients. This mechanism also affects your brain's reward pathways related to food, often reducing cravings for high-calorie foods whilst promoting preference for healthier options. Understanding this biological process helps explain why side effects occur and reassures patients that these changes indicate the medication is working as intended. The gradual dose escalation allows your body to adapt to these changes progressively, minimising discomfort whilst maximising therapeutic benefits.
EverydayMeds Ordering Process: Professional Support from Day One
Starting Wegovy through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for semaglutide treatment whilst identifying potential risk factors for side effects. Our qualified prescribers review every application individually, typically within 3 working days (express 24-hour review available), ensuring appropriate clinical oversight before treatment begins. Once approved, your 0.25mg starter pen is dispatched via next-day delivery using specialised cold-chain packaging to maintain the 2-8°C temperature requirements. Each delivery includes detailed administration instructions, side effect management guidance, and direct contact details for our clinical support team. Our GPhC-registered pharmacy (#9012878) operates under strict MHRA regulations, ensuring every Wegovy pen meets pharmaceutical quality standards whilst providing ongoing clinical support throughout your treatment journey.
Storage and Practical Considerations for Wegovy Starters
Proper Wegovy storage is crucial for maintaining medication efficacy and safety, especially when understanding when side effects start relates to correct dosing. Your 0.25mg pen must be stored in the fridge at 2-8°C before first use, though it can remain at room temperature (below 30°C) for up to 6 weeks once removed, offering excellent travel flexibility compared to other GLP-1 medications. Each FlexTouch pen is pre-filled for four weekly injections, with clear dose escalation instructions provided for progression to 0.5mg after week 4. The pen's built-in safety features prevent accidental overdosing, whilst the ultra-fine needle minimises injection discomfort. Never skip the dose escalation schedule, as this significantly increases side effect severity and reduces treatment tolerability, potentially compromising your long-term success with Wegovy. Following the prescribed escalation timeline ensures optimal balance between therapeutic effectiveness and manageable side effects.
Managing Early Side Effects: Your First Month Strategy
When Wegovy side effects start during your first month, having a practical management strategy significantly improves your treatment experience and adherence. Nausea, the most common early side effect, typically peaks 2-4 hours after injection and can be minimised by eating smaller, more frequent meals and avoiding fatty or spicy foods on injection days. Many patients find that injecting before bedtime reduces daytime nausea, whilst staying well-hydrated helps manage any digestive discomfort that may occur. Keeping a symptom diary during your first month helps identify patterns and triggers, enabling better side effect prediction and management strategies.
The psychological adjustment to reduced appetite often surprises new patients, as feeling satisfied with smaller portions can initially feel unusual after years of larger meal habits. Embracing this change as positive progress, rather than concerning side effect, helps maintain motivation during early treatment phases. Our clinical team recommends focusing on nutrient-dense foods during this appetite adjustment period, ensuring adequate protein and vitamin intake despite reduced overall consumption. Remember that these early side effects typically diminish significantly by week 6-8 as your body adapts to semaglutide, making the initial adjustment period a temporary phase towards long-term success.
Professional Clinical Support Throughout Your Wegovy Journey
EverydayMeds provides comprehensive clinical support specifically designed around the question of when Wegovy side effects start and how to manage them effectively. Our qualified clinical team, operating under GPhC registration #9012878, offers direct telephone and email support for any concerns during your first month of treatment. We understand that starting any prescription-only medicine requires professional guidance, particularly with medications affecting appetite and digestion like Wegovy. Whether you experience side effects within the first 24 hours or have questions about dose escalation timing, our clinical professionals provide evidence-based advice tailored to your individual circumstances. Begin your Wegovy journey with confidence by ordering your 0.25mg starter dose for £79.99, using code FIRST40 at checkout, and accessing our comprehensive support network designed specifically for patients beginning semaglutide treatment alongside a reduced-calorie diet and increased physical activity.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
